Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A disease involving the stomach.
Biomarker and diagnostic research for stomach disorder has been reported in the published literature.
5 clinical trials registered. Interventions under study include drug therapy and procedural interventions. Pipeline includes 1 PHASE2, 3 NA. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT05602935](https://clinicaltrials.gov/study/NCT05602935) |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 11:58 PM UTC
Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study
PHASE2 |
The Second Affiliated Hospital of Fujian Medical University |
UNKNOWN |
[NCT06340828](https://clinicaltrials.gov/study/NCT06340828) | Washed Microbiota Transplantation Alleviates Diabetic Gastrointestinal Motility Disorders: an Efficacy and Safety Study | NA | The Second Hospital of Nanjing Medical University | NOT_YET_RECRUITING |
[NCT06719466](https://clinicaltrials.gov/study/NCT06719466) | Diet Intervention on Obesity Related Complication | NA | Zhang Manna | UNKNOWN |
[NCT06958250](https://clinicaltrials.gov/study/NCT06958250) | Novel Endoscopic Bite Block | NA | University of Pennsylvania | UNKNOWN |
[NCT06555276](https://clinicaltrials.gov/study/NCT06555276) | Post-market Clinical Follow-up of Disposable Endoscope Linear Cutting Staplers and Components | — | Suzhou Care-Real Medical Technology Co., Ltd. | UNKNOWN |
161 publications have been identified in PubMed for stomach disorder. Research spans Basic Science / Preclinical (32%), Review / Meta-Analysis (26%), and Epidemiology / Natural History (17%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 52 | 32% |
Research summaries | 42 | 26% |
Disease patterns and progression | 28 | 17% |
Testing and diagnosis research | 14 | 9% |
Patient case studies | 13 | 8% |
Clinical study results | 6 | 4% |
New treatment approaches | 5 | 3% |
Other research | 1 | 1% |
Lahner E (2026). [PMID: 41198445](https://pubmed.ncbi.nlm.nih.gov/41198445/). *Dig Liver Dis*. [Review / Meta-Analysis]
Wang J (2026). [PMID: 41589618](https://pubmed.ncbi.nlm.nih.gov/41589618/). *Autoimmunity*. [Review / Meta-Analysis]
Abdisa G (2026). [PMID: 42119868](https://pubmed.ncbi.nlm.nih.gov/42119868/). *J Ethnopharmacol*. [Basic Science / Preclinical]
Michelon I (2026). [PMID: 41517847](https://pubmed.ncbi.nlm.nih.gov/41517847/). *J Gastric Cancer*. [Review / Meta-Analysis]
Törnblom H (2026). [PMID: 41713705](https://pubmed.ncbi.nlm.nih.gov/41713705/). *Gastroenterology*. [Review / Meta-Analysis]
Gawron J (2026). [PMID: 41511880](https://pubmed.ncbi.nlm.nih.gov/41511880/). *Blood*. [Gene Therapy / Novel Therapeutics]
Mülder DT (2026). [PMID: 41236450](https://pubmed.ncbi.nlm.nih.gov/41236450/). *Gastroenterology*. [Review / Meta-Analysis]
Er RE (2026). [PMID: 40662330](https://pubmed.ncbi.nlm.nih.gov/40662330/). *J Investig Med*. [Epidemiology / Natural History]
Mansour RM (2025). [PMID: 40348207](https://pubmed.ncbi.nlm.nih.gov/40348207/). *Microbial pathogenesis*. [Case Report / Case Series]
Chen Y (2025). [PMID: 39961485](https://pubmed.ncbi.nlm.nih.gov/39961485/). *Clinics and research in hepatology and gastroenterology*. [Epidemiology / Natural History]